These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6151206)

  • 1. Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepam.
    Ansseau M; Doumont A; von Frenckell R; Collard J
    Psychopharmacology (Berl); 1984; 84(3):293-8. PubMed ID: 6151206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of prazepam drops in the brief treatment of anxiety disorders].
    Ansseau M; Von Frenckell R
    Encephale; 1991; 17(4):291-4. PubMed ID: 1959497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients.
    Saletu M; Saletu B; Grünberger J; Mader R; Karobath M
    Neuropsychobiology; 1983; 9(2-3):119-34. PubMed ID: 6353268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care].
    Chabannes JP; Lemoine P
    Therapie; 1990; 45(6):467-70. PubMed ID: 2080484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
    Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D
    Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of prazepam with diazepam, chlorazepate dipotassium and placebo in anxious out-patients.
    Fabre LF; McLendon DM; Mallette A
    J Int Med Res; 1979; 7(2):147-51. PubMed ID: 39012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
    Dorman T
    Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled comparison of two anxiolytic benzodiazepines, cloxazolam and bromazepam.
    Ansseau M; von Frenckell R
    Neuropsychobiology; 1990-1991; 24(1):25-9. PubMed ID: 1983433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety].
    Guelfi JD; Lancrenon S; Millet V
    Encephale; 1993; 19(5):547-52. PubMed ID: 8306923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC; O'Hair DE
    Clin Ther; 1980; 3(3):209-18. PubMed ID: 6109568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazepam and lorazepam, two new benzodiazepines.
    Greenblatt DJ; Shader RI
    N Engl J Med; 1978 Dec; 299(24):1342-4. PubMed ID: 30899
    [No Abstract]   [Full Text] [Related]  

  • 15. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.
    Weir JH
    J Clin Psychiatry; 1978 Dec; 39(12):841-7. PubMed ID: 721788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety.
    Goldberg HL; Finnerty RJ
    Compr Psychiatry; 1977; 18(2):147-55. PubMed ID: 319941
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam.
    Shader RI; Pary RJ; Harmatz JS; Allison S; Locniskar A; Greenblatt DJ
    J Clin Psychiatry; 1984 Oct; 45(10):411-3. PubMed ID: 6148339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of the anxiolytic activity of two benzodiazepines, metaclazepam and bromazepam, in anxiety neurosis.
    Bilone F; Roncari R
    Curr Med Res Opin; 1988; 11(1):45-7. PubMed ID: 2898321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.